NEW YORK (GenomeWeb News) — Roche plans to acquire NimbleGen Systems for $272.5 million, the Swiss biotech giant said today.
 
Saying that NimbleGen’s arrays complement Roche’s ongoing genomics campaigns, Roche Diagnostics CEO Severin Schwan said the deal is part of the company’s strategy to gain ground in the genomics research market by “extending our activities into the microarray segment.”
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.